diabetes management app
Western Sydney Diabetes adopts the mobile solution to automate patient engagement.
SugoSure targets patients with type 2 diabetes below 65 years old.
Healthcare providers use a web interface to prescribe an initial dose "and BlueStar does the rest," according to Welldoc's chief medical officer.
Astellas will be paying Welldoc $15 million up front for certain rights to the diabetes digital therapeutic, and will also be on the hook for milestones and royalty payments.
This is the seventh FDA clearance for the longstanding mobile diabetes management platform.
The Sugar.IQ digital diabetes assistant will use AI analytics to predict users' low blood sugar risk within the next one to four hours.
Once prompted, data from the Contour Diabetes app and Contour Next One glucometer will automatically populate within the Apple feature's Blood Glucose section.
Also: Group K Diagnostics raises $2 million; Online depression intervention benefits high-risk teens.
Fit4D, a New York City-based diabetes management platform, announced another round of funding to expand its innovation efforts.